- Home
- IMNM vs WRBY Comparison
IMNM vs WRBY Comparison
Compare IMNM & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | WRBY |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMNM | WRBY |
|---|---|---|
| Price | $19.42 | $23.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 16 |
| Target Price | ★ $26.89 | $24.47 |
| AVG Volume (30 Days) | 1.2M | ★ 3.8M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $9,679,000.00 | ★ $850,580,000.00 |
| Revenue This Year | N/A | $15.47 |
| Revenue Next Year | N/A | $12.84 |
| P/E Ratio | ★ N/A | $9,344.06 |
| Revenue Growth | N/A | ★ 14.55 |
| 52 Week Low | $5.15 | $13.63 |
| 52 Week High | $20.46 | $29.73 |
Technical Indicators
Market Signals| Indicator | IMNM | WRBY |
|---|---|---|
| Relative Strength Index (RSI) | 60.95 | 69.30 |
| Support Level | $16.81 | $17.83 |
| Resistance Level | $20.46 | $19.32 |
| Average True Range (ATR) | 1.20 | 1.20 |
| MACD | 0.03 | 0.62 |
| Stochastic Oscillator | 72.74 | 97.51 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.